Cancer in Young Adults Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase 1/2 Dose Escalation Study of CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Conditions: Acute Lymphoid Leukemia; B-Cell Leukemia; Leukemia, Lymphocytic, B Cell; B-Cell Lymphoma; Lymphoma, Non-Hodgkin Interventions: Drug: fludarabine; Drug: cyclophosphamide; Biological: CD19/CD22-CAR-transduced T cells Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2022 Category: Research Source Type: clinical trials

Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults at Risk for Polytobacco Use
Discussion; Behavioral: Health Education; Other: Interview; Other: Survey Administration Sponsors: Ohio State University Comprehensive Cancer Center; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2022 Category: Research Source Type: clinical trials